Read more
Fully revised throughout, the second edition of Manual of Stem Cell and Bone Marrow Transplantation is based on the in-house handbook used at the world-renowned Dana-Farber Cancer Institute. It is a practical pocket manual for all members of the stem cell and bone marrow transplant team. Written by experts at Dana-Farber, the contents are handily arranged in outline format for maximum usefulness and convenience. This essential and user-friendly manual covers all aspects of the transplantation process, from stem cell processing through management of transplant-related complications. Topics discussed thoroughly include evaluation and counselling of patients and donors, preventative care, graft-versus-host disease and conditioning regimens. A new extensive chapter on oral health in stem cell transplantation has been added. These features make the Manual of Stem Cell and Bone Marrow Transplantation an ideal resource for the entire transplant team.
List of contents
Acknowledgements; 1. Rationale for transplantation; 2. Types of transplantation; 3. HLA matching in allogeneic transplantation; 4. Stem cell source; 5. Pre-transplant evaluation and counselling of patient and donor; 6. Conditioning regimens; 7. Stem cell infusion; 8. ABO compatibility; 9. Engraftment; 10. Preventative care; 11. Transplant-related complications; 12. Overview of acute and chronic graft-versus-host disease; 13. Acute graft-versus-host disease and staging; 14. Graft-versus-host prophylactic regimens; 15. Treatment guidelines for acute graft-versus-host disease; 16. Chronic graft-versus-host disease; 17. Engraftment syndrome; 18. Infectious disease; 19. Graft rejection and failure; 20. Gastrointestinal complications; 21. Oral health in stem cell transplantation; 22. Pulmonary complications; 23. Veno-occlusive disease; 24. Special transfusion-related situations; 25. Cardiovascular complications; 26. Neurologic complications; 27. Cystitis; 28. Donor lymphocyte infusion; 29. Transplantation: regulation and accreditation; Index.
About the author
Joseph H. Antin is Professor of Medicine at Harvard Medical School and Chief of the Stem Cell Transplant Program at the Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA.Deborah Yolin Raley is the Director of the Physician Assistant Program and a practising Physician Assistant in the Hematopoietic Stem Cell Transplant Program at the Dana-Farber Cancer Institute, Boston, MA, USA.
